Biotech Startup Eyestem Raises $6.4 Mn To Build Cell Therapy Products
08 Aug’22 ,MONDAY The round was led by Biological E. Ltd, Alkem, NATCO, Anurag Bagaria and Karan Bagaria from Kemwell Biopharma Eyestem will use the capital to solidify its cell therapy platform and conduct early clinical trials of its patented product Its patented product called Eyecyte-RPE is an experimental treatment for dry age-related macular degeneration. …
Biotech Startup Eyestem Raises $6.4 Mn To Build Cell Therapy Products Read More »
